All comparisons
Head-to-head
Nippon India Pharma Fund - Direct Plan - Growth OptionvsDSP Healthcare Fund - Direct Plan - Growth
Side-by-side comparison of Nippon India Pharma Fund - Direct Plan - Growth Option and DSP Healthcare Fund - Direct Plan - Growth — returns, bumpiness, category, and AUM. Winners per row are marked with . Descriptive numbers only, no recommendations.
₹1 lakh over time
What ₹1,00,000 invested at the start of each window would have become in each fund.
sector
Nippon India Pharma Fund - Direct Plan - Growth Option
3Y ago₹1.72 L
5Y ago₹1.91 L
sector
DSP Healthcare Fund - Direct Plan - Growth
3Y ago₹1.84 L
5Y ago₹2.05 L
Normalised price over time
Both funds start at ₹100 at the beginning of the range so shapes are directly comparable.
Normalized: value at the start of the selected range = ₹100
Every metric, side-by-side
marks the winner per row.
| Metric | Nippon India Pharma Fund - Dire… | DSP Healthcare Fund - Direct Pl… |
|---|---|---|
| Fund house | Nippon India Mutual Fund | DSP Mutual Fund |
| Category | Equity Schemes - Sectoral Fund | Equity Schemes - Sectoral Fund |
| Latest NAV | ₹647.5641 | ₹51.174 |
| Assets managed (AUM) | — | — |
| 1Y return | 14.06% | 17.93% |
| 3Y CAGR | 19.72% | 22.55% |
| 5Y CAGR | 13.85% | 15.40% |
| Since inception CAGR | 17.70% | 23.35% |
| Bumpiness · 3Y (annualised σ) | 12.97 | 12.82 |
| Worst drop ever | -24.02% | -21.74% |
| Sharpe · 3Y (rf=6%) | 0.96 | 1.21 |
Explore each fund individually
Nippon India Pharma Fund - Direct Plan - Growth Option →DSP Healthcare Fund - Direct Plan - Growth →
Want to compare more than two? Add up to 3 more funds on the full compare page.